(Q43621188)

25 November 2017

title

Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure (English)

1 reference

25 November 2017

0 references

0 references

1 reference

chronic heart failure

1 reference

R A de Boer

1

1 reference

25 November 2017

H J Siebelink

2

1 reference

25 November 2017

R A Tio

3

1 reference

25 November 2017

F Boomsma

4

1 reference

25 November 2017

D J van Veldhuisen

5

1 reference

25 November 2017

publication date

1 June 2001

1 reference

European Journal of Heart Failure

25 November 2017

published in

1 reference

25 November 2017

volume

3

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

331-333

1 reference

Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Revascularisation for chronic heart failure: a valid option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

The hypoxic response: huffing and HIFing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Capillary growth and changes in heart performance induced by chronic bradycardial pacing in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900129-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S1388-9842(01)00129-5

1 reference

25 November 2017

1 reference